Skip to main content

Market Overview

20 Healthcare Stocks Moving In Tuesday's Pre-Market Session

Share:

Gainers

CymaBay Therapeutics, Inc. (NASDAQ:CBAY) shares increased by 144.02% to $4.49 during Tuesday's pre-market session. The most recent rating by Cantor Fitzgerald, on May 12, is at Overweight, with a price target of $15.

Gamida Cell, Inc. (NASDAQ:GMDA) shares moved upwards by 67.40% to $7.60. The most recent rating by HC Wainwright & Co., on Apr 27, is at Buy, with a price target of $15.

Helius Medical, Inc. (NASDAQ:HSDT) shares moved upwards by 54.12% to $0.66.

Novavax, Inc. (NASDAQ:NVAX) stock rose 48.90% to $36.48. The most recent rating by H.C. Wainwright, on May 12, is at Buy, with a price target of $50.

Akorn, Inc. (NASDAQ:AKRX) shares moved upwards by 45.31% to $0.37.

Macrogenics, Inc. (NASDAQ:MGNX) stock rose 21.12% to $31.88. The most recent rating by Credit Suisse, on May 6, is at Outperform, with a price target of $13.

Fluidigm, Inc. (NASDAQ:FLDM) shares rose 12.04% to $5.49.

Redhill Biopharma, Inc. (NASDAQ:RDHL) shares moved upwards by 10.50% to $8. The most recent rating by H.C. Wainwright, on Mar 5, is at Buy, with a price target of $14.

Diffusion Pharmaceuticals, Inc. (NASDAQ:DFFN) shares rose 10.20% to $0.81.

Guardion Health Sciences, Inc. (NASDAQ:GHSI) stock increased by 10% to $0.55.

 

Losers

Genfit, Inc. (NASDAQ:GNFT) shares decreased by 65.48% to $7.49 during Tuesday's pre-market session. The most recent rating by SVB Leerink, on May 12, is at Outperform, with a price target of $20.

Nabriva Therapeutics, Inc. (NASDAQ:NBRV) stock declined 14.93% to $0.62. According to the most recent rating by H.C. Wainwright, on Apr 9, the current rating is at Neutral.

Marker Therapeutics, Inc. (NASDAQ:MRKR) shares fell 10.08% to $2.23. The most recent rating by Piper Sandler, on May 12, is at Neutral, with a price target of $2.

DBV Technologies, Inc. (NASDAQ:DBVT) stock decreased by 9.42% to $5.58. The most recent rating by Citigroup, on Apr 6, is at Buy, with a price target of $10.

Cellect Biotechnology, Inc. (NASDAQ:APOP) shares declined 8.86% to $3.60.

Akebia Therapeutics, Inc. (NASDAQ:AKBA) shares declined 6.61% to $12. The most recent rating by JP Morgan, on May 6, is at Overweight, with a price target of $18.

Ra Medical Systems, Inc. (NYSE:RMED) stock declined 5.50% to $1.03. The most recent rating by Cantor Fitzgerald, on Mar 11, is at Neutral, with a price target of $2.

Tilray, Inc. (NASDAQ:TLRY) stock declined 4.08% to $7.75. The most recent rating by Cantor Fitzgerald, on May 11, is at Neutral, with a price target of $7.

Cellectis, Inc. (NASDAQ:CLLS) shares fell 3.09% to $14.75. The most recent rating by Goldman Sachs, on Mar 6, is at Sell, with a price target of $11.

Ocugen, Inc. (NASDAQ:OCGN) shares fell 3.03% to $0.32.

 

Related Articles (CBAY + GMDA)

View Comments and Join the Discussion!

Posted-In: Healthcare Stocks Pre-Market MoversPre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com